Late Breaking Abstract - The impact of treatment with mepolizumab on airway remodeling in patients with severe eosinophilic asthma. Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021
Induced sputum and airway inflammation in asthma and COPD Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006
Late Breaking Abstract - Mepolizumab reduces exacerbations in eosinophilic COPD Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017
Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008
Modulation of Eosinophilic airway inflammation in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 441s Year: 2005
Stability of eosinophilic inflammation in COPD bronchial biopsies Source: Eur Respir J, 56 (5) 2000622; 10.1183/13993003.00622-2020 Year: 2020
Stability of eosinophilic inflammation in COPD bronchial biopsies Source: Eur Respir J, 56 (6) 2004167; 10.1183/13993003.04167-2020 Year: 2020
Stability of eosinophilic inflammation in COPD bronchial biopsies Source: Eur Respir J, 56 (6) 2003802; 10.1183/13993003.03802-2020 Year: 2020
Eosinophilic airway inflammation in COPD and asthma Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008
Late Breaking Abstract - Effect of timapiprant, a DP2 antagonist, on airway inflammation in severe eosinophilic asthma Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma Year: 2019
Peripheral blood eosinophilia predicts lower airway eosinophilia in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015
Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017
Induced sputum and bronchial hyperresponsiveness in COPD patients Source: International Congress 2014 – Airway biomarkers Year: 2014
Late Breaking Abstract - Benralizumab treatment strongly reduces blood basophils in patients with severe eosinophilic asthma Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019
Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients Source: International Congress 2014 – Translational studies in COPD Year: 2014
Bronchial reversibility and airway inflammation in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003
Role of neutrophils in airway inflammation in patients with pneumoconiosis and COPD Source: Eur Respir J 2004; 24: Suppl. 48, 322s Year: 2004
Induced sputum in asthma and COPD: meassuring type and inflammation activity Source: Eur Respir J 2003; 22: Suppl. 45, 76s Year: 2003
Corticosteroid increased apoptosis of airway sputum macrophages from patients with COPD and emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001
Induced sputum to assess bronchial inflammation in children with intermittent athopic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 399s Year: 2003